Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Sanofi supports Clexane with Spanish VTE apps

The free iPhone, iPad and Android apps are for healthcare professionals

Sanofi Clexane iPhone app 

Sanofi Spain has launched new mobile apps to help healthcare professionals in the country manage their patients with venous thromboembolism (VTE).

The free apps will run on iPhone, iPad and Android devices and will support prescribers who choose its anticoagulant Clexane (enoxaparin).

The drug is the leading low molecular weight heparin (LMWH), but is being challenged by new types of anticoagulants such as Bayer's Xarelto (rivaroxaban) and Boehringer Ingelheim's Pradaxa (dabigatran).

The first of Sanofi's new apps, CLX Dosis, is a dose calculator for LMWHs, based on the patient's weight, for the treatment of VTE, pulmonary embolism and deep vein thromobosis.

The second, CLX Cesarean, is another dose calculator for the prophylaxis treatment of VTE (venous thromboembolism) in women with risk factors for emergency caesarean-after labour.

Based on guidelines from the Royal College of Obstetricians and Gynaecologists, CLX Cesarean defines the dose of low molecular weight heparin prenatal and postnatal care to prevent the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Commenting on the launch of these two apps Sanofi said they should allow healthcare professionals to more quickly and more conveniently work out the correct dosing for LMWHs compared to consulting the guidelines in their paper-based form.

Meanwhile, the company has recently launched a third Clexane-focused app, CLX Caprini. This is based on Professor Joseph Caprini's model for evaluating and weighting the main risk factors for VTE in patients undergoing surgical procedures.

15th April 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics